![\"CAR-T](\"https:\/\/i0.wp.com\/kccrc.org\/news\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-Mar-13-2026-02_11_32-PM.png?resize=600%2C400&ssl=1\")
<\/p>\n\n\n\n<\/p>\n\n\n\n
Cancer treatment has evolved rapidly over the last decade. One of the most exciting advances is CAR T-cell therapy<\/strong>, a form of personalized immunotherapy that uses a patient\u2019s own immune system to fight cancer.<\/p>\n\n\n\n This revolutionary treatment has transformed outcomes for some patients with difficult-to-treat blood cancers such as Acute Lymphoblastic Leukemia<\/strong> and Diffuse Large B\u2011Cell Lymphoma<\/strong>.<\/p>\n\n\n\n Unlike traditional chemotherapy, CAR-T therapy works by reprogramming immune cells to recognize and destroy cancer cells<\/strong>.<\/p>\n\n\n\n The human immune system constantly patrols the body to identify infections and abnormal cells. Among the most important immune cells are T-cells<\/strong>, which play a central role in detecting threats.<\/p>\n\n\n\n However, cancer cells can sometimes evade detection by the immune system. Scientists developed CAR-T therapy to enhance the ability of T-cells to recognize cancer cells more effectively<\/strong>.<\/p>\n\n\n\n CAR-T therapy stands for Chimeric Antigen Receptor T-cell therapy<\/strong>. It involves several key steps.<\/p>\n\n\n\n Doctors collect T-cells from the patient\u2019s blood through a process called apheresis<\/strong>.<\/p>\n\n\n\n In a specialized laboratory, scientists modify the T-cells by inserting a gene that allows them to recognize a specific protein on cancer cells, often CD19<\/strong>.<\/p>\n\n\n\n The modified cells are multiplied until millions of CAR-T cells are produced.<\/p>\n\n\n\n The engineered cells are infused back into the patient, where they begin to recognize and destroy cancer cells.<\/p>\n\n\n\n Because these cells can continue to grow and function in the body, CAR-T therapy can provide long-lasting anti-cancer activity<\/strong>.<\/p>\n\n\n\n In 2017, the U.S. Food and Drug Administration<\/strong> approved the first CAR-T therapy called Kymriah<\/strong>, developed by Novartis<\/strong>.<\/p>\n\n\n\n The therapy, also known scientifically as Tisagenlecleucel<\/strong>, was approved for:<\/p>\n\n\n\n This approval marked a historic moment in cancer medicine, as it was the first gene-modified cell therapy approved for cancer treatment<\/strong>.<\/p>\n\n\n\n Currently, CAR-T therapy is mainly used for certain blood cancers<\/strong>, including:<\/p>\n\n\n\n Research is also exploring CAR-T therapy for:<\/p>\n\n\n\n Scientists around the world are developing CAR-T therapies targeting different cancer markers to expand the number of cancers that can be treated.<\/p>\n\n\n\n Clinical trials published in leading journals such as the New England Journal of Medicine<\/strong> have shown impressive results.<\/p>\n\n\n\n In patients with relapsed leukemia or lymphoma who had limited treatment options, CAR-T therapy has produced high remission rates<\/strong>, with many patients achieving durable responses.<\/p>\n\n\n\n For some patients, the treatment can lead to long-term cancer control or possible cure<\/strong>.<\/p>\n\n\n\n Like any powerful cancer treatment, CAR-T therapy can cause side effects.<\/p>\n\n\n\n One of the most important complications is Cytokine Release Syndrome (CRS)<\/strong>, which occurs when immune cells become highly activated.<\/p>\n\n\n\n Symptoms may include:<\/p>\n\n\n\n Doctors are trained to manage this condition, often using medications such as Tocilizumab<\/strong> when necessary.<\/p>\n\n\n\n Because of these risks, CAR-T therapy is performed only at specialized centers with expertise in advanced cancer care.<\/p>\n\n\n\n CAR-T therapy is part of a new generation of treatments known as cellular and gene therapies<\/strong>.<\/p>\n\n\n\n These therapies aim to train the immune system to fight cancer more effectively<\/strong>, rather than relying only on chemotherapy or radiation.<\/p>\n\n\n\n Researchers believe that in the coming years, CAR-T therapy may expand to treat many additional cancers.<\/p>\n\n\n\n At Kathmandu Cancer Center<\/strong>, specialists in hematology and oncology are working to build advanced cellular therapy programs, including CAR-T cell therapy<\/strong>, to bring next-generation cancer treatments closer to patients in Nepal.<\/p>\n\n\n\n This development would reduce the need for patients to travel abroad for complex treatments such as:<\/p>\n\n\n\n These developments aim to bring world-class cancer treatment closer to patients in Nepal<\/strong>.<\/p>\n\n\n\n If you want to understand how this treatment may help patients with leukemia or lymphoma, read our detailed guide on:<\/p>\n\n\n\n CAR-T Cell Therapy in Nepal<\/a><\/strong><\/p>\n\n\n\n <\/p>\n\n Understanding the Immune System and Cancer
<\/h2>\n\n\n\nHow CAR-T Cell Therapy Works<\/h2>\n\n\n\n
1. Collection of Immune Cells<\/h3>\n\n\n\n
2. Genetic Engineering<\/h3>\n\n\n\n
3. Expansion of Cells<\/h3>\n\n\n\n
4. Infusion Back into the Patient<\/h3>\n\n\n\n
\n\n\n\nThe First Approved CAR-T Therapy<\/h2>\n\n\n\n
\n
\n\n\n\nWhich Cancers Can CAR-T Therapy Treat?<\/h2>\n\n\n\n
Leukemia<\/h3>\n\n\n\n
\n
Lymphoma<\/h3>\n\n\n\n
\n
\n
\n\n\n\nHow Effective is CAR-T Therapy?<\/h2>\n\n\n\n
\n\n\n\nPossible Side Effects<\/h2>\n\n\n\n
\n
\n\n\n\nThe Future of Cancer Treatment<\/h2>\n\n\n\n
\n\n\n\nCAR-T Therapy and Cancer Care in Nepal<\/h2>\n\n\n\n
\n
\n\n\n\nLearn More About CAR-T Therapy<\/h1>\n\n\n\n